Skip to main content

Richard Andrew Krasuski

Professor of Medicine
Medicine, Cardiology

Overview


Dr. Richard Krasuski is Director of the Adult Congenital Heart Center at Duke University Medical Center, the Director of Hemodynamic Research, and the Medical Director of the CTEPH Program. He is considered a thought leader in the fields of pulmonary hypertension and congenital heart disease. His research focus is in epidemiologic and clinical studies involving patients with pulmonary hypertension and patients with congenital heart disease. He is involved in multiple multicenter studies through the Alliance for Adult Research in Congenital Cardiology (AARCC). He has also helped to develop multiple research databases in these patient populations. He is Co-PI in the upcoming EPIPHANY Study examining the impact of medical and transcatheter interventions on RV-PA coupling in patients with chronic thromboembolic pulmonary hypertension. Over his career he has mentored over 80 students, residents and fellows and has published over 300 peer reviewed publications, book chapters and meeting abstracts. He is also the Chief Editor of Advances in Pulmonary Hypertension and on the editorial boards of several leading medical journals.

Current Appointments & Affiliations


Professor of Medicine · 2016 - Present Medicine, Cardiology, Medicine

In the News


Published May 11, 2023
1 in 5 Brain Injury Trials Show Errors, Signs of Spin
Published December 8, 2022
Doctors should ask heart patients if they take supplements to manage heart failure
Published May 6, 2019
'No-Spin Zone'? Not in Cardiology

View All News

Recent Publications


Challenges and Growing experience in Heart Transplantation in Adult Congenital Heart Disease.

Journal Article Can J Cardiol · November 21, 2025 With advances in congenital heart disease (CHD) management, most infants now survive into adulthood. Heart failure (HF) remains the leading cause of death in this growing adult cohort. CHD patients can present with unique characteristics of failure, not on ... Full text Link to item Cite

Abstract 4369029: Regional and Temporal Mortality Trends of Congenital Cardiovascular Malformations in Patients with Chromosomal Abnormalities in the United States from 1999 to 2020

Conference Circulation · November 4, 2025 Background: Congenital cardiovascular malformations (CVMs) affect 0.5 to 0.7% of all live born infants. Chromosomal abnormalities (CA) both increase CVM severity and contribute to high ... Full text Cite

Abstract 4369193: Burden of Heart Failure in 4,573 Children and Adults with Fontan Physiology: Epidemiology and Outcomes from a Decade-Long Seven-State US-Based Surveillance Network

Conference Circulation · November 4, 2025 Introduction: The prevalence of heart failure (HF) among U.S. patients (pts) with Fontan physiology is poorly defined, with estimates generally derived from single centers. We leverage ... Full text Cite
View All Publications

Recent Grants


Occluflex

Clinical TrialCo-Principal Investigator · Awarded by Occlutech US LLC · 2024 - 2025

Peer Coaching Adaptive Self-Management Interventions for Young Adults with Congenital Heart Disease (CHASM IN ACHD)

ResearchPrincipal Investigator · Awarded by Adult Congenital Heart Association · 2019 - 2023

Insmed TPIP

Clinical TrialPrincipal Investigator · Awarded by Insmed · 2021 - 2023

View All Grants

Education, Training & Certifications


Harvard Medical School · 1994 M.D.